Pet healthcare innovation company, IDEXX Laboratories Inc. announced the promotion of Michael Erickson, PhD, to president and chief executive officer, effective May 12, 2026.

Dr. Erickson will succeed Jonathan Mazelsky, who will become executive chair of the board and retire after the company’s annual meeting in May 2027. Erickson has nearly two decades of healthcare experience and has held various senior roles at IDEXX since joining in 2011.

“IDEXX is at the centre of the veterinary ecosystem and has an immense opportunity to build on our more than 40-year history of innovation to advance medical care and help our customers navigate the complexities of modern veterinary medicine,” said Erickson.

Board chair Lawrence D. Kingsley emphasized the careful leadership transition strategy behind this decision, highlighting Erickson’s deep understanding of the company.

“Mike’s appointment as the company’s next president and CEO is the culmination of the IDEXX board’s thoughtful and robust succession planning process,” said Kingsley.